Novo Nordisk shares tumble after company warns of sales hit this year
The company is banking on its Wegovy pill and next-generation weight loss injectable CagriSema to recapture share of the key U.S. market.
Disney just announced its new CEO. Here’s what it means for investors
Investors analyzed Disney’s decision to tap parks chief Josh D’Amaro as the successor to CEO Bob Iger.
Trump Project Vault stockpile will include any minerals listed as ‘critical’ by Interior Department
The stockpile is the latest move by the Trump administration to build a Western supply chain to counter China’s dominance in critical minerals.
Musk’s xAI, SpaceX combo is the biggest merger of all time, valued at $1.25 trillion
The record-setting deal will be the largest merger of all time and is valued at $1.25 trillion
Spain becomes first country in Europe to ban social media for under-16s
Spain’s Prime Minister Pedro Sanchez urges the protection of children from a “digital wild west.”
World’s largest jeweler under pressure as analysts warn it will be hit by volatile silver price
Jefferies analysts downgraded Pandora to Hold. Rising costs are squeezing its margins, as is a worsening macroeconomic backdrop.
PayPal shares plunge nearly 20% on CEO exit, disappointing 2026 profit forecast
PayPal logged revenue of $8.68 billion for the quarter, missing estimates of $8.80 billion. Adjusted profit was $1.23 a share, also below analysts’ forecasts.
Ray Dalio warns the world is ‘on the brink’ of a capital war
The billionaire Bridgewater founder also weighed in on investing in gold after the metal was gripped by a sharp sell-off.
Palantir soars after strong earnings. What analysts highlighted, including accelerating AI demand
Analysts remained overwhelmingly bullish on Palantir, although the company’s lofty valuation stood out as a sore spot for some.
Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial
The data on Pfizer’s GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs without sacrificing efficacy.
